CANADIAN NORTH RESOURCES INC (CNRI.CA) Fundamental Analysis & Valuation

TSX-V:CNRI • CA1364271017

Current stock price

0.305 CAD
+0.04 (+15.09%)
Last:

This CNRI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CNRI.CA Profitability Analysis

1.1 Basic Checks

  • CNRI had negative earnings in the past year.
  • CNRI had a negative operating cash flow in the past year.
  • CNRI had negative earnings in each of the past 5 years.
  • In the past 5 years CNRI always reported negative operating cash flow.
CNRI.CA Yearly Net Income VS EBIT VS OCF VS FCFCNRI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • With an excellent Return On Assets value of -1.52%, CNRI belongs to the best of the industry, outperforming 81.01% of the companies in the same industry.
  • CNRI has a better Return On Equity (-1.62%) than 81.89% of its industry peers.
Industry RankSector Rank
ROA -1.52%
ROE -1.62%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNRI.CA Yearly ROA, ROE, ROICCNRI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • CNRI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNRI.CA Yearly Profit, Operating, Gross MarginsCNRI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CNRI.CA Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for CNRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CNRI.CA Yearly Shares OutstandingCNRI.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 20M 40M 60M 80M 100M
CNRI.CA Yearly Total Debt VS Total AssetsCNRI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

  • CNRI has an Altman-Z score of 6.48. This indicates that CNRI is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 6.48, CNRI perfoms like the industry average, outperforming 57.86% of the companies in the same industry.
  • There is no outstanding debt for CNRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.48
ROIC/WACCN/A
WACCN/A
CNRI.CA Yearly LT Debt VS Equity VS FCFCNRI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

  • A Current Ratio of 0.34 indicates that CNRI may have some problems paying its short term obligations.
  • The Current ratio of CNRI (0.34) is worse than 74.21% of its industry peers.
  • CNRI has a Quick Ratio of 0.34. This is a bad value and indicates that CNRI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CNRI has a Quick ratio of 0.34. This is in the lower half of the industry: CNRI underperforms 73.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
CNRI.CA Yearly Current Assets VS Current LiabilitesCNRI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CNRI.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 81.87% over the past year.
EPS 1Y (TTM)81.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CNRI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CNRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNRI.CA Price Earnings VS Forward Price EarningsCNRI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNRI.CA Per share dataCNRI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CNRI.CA Dividend Analysis

5.1 Amount

  • CNRI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CNRI.CA Fundamentals: All Metrics, Ratios and Statistics

CANADIAN NORTH RESOURCES INC

TSX-V:CNRI (3/31/2026, 7:00:00 PM)

0.305

+0.04 (+15.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners11.53%
Ins Owner ChangeN/A
Market Cap34.87M
Revenue(TTM)N/A
Net Income(TTM)-696.40K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.52%
ROE -1.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -2160.17%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z 6.48
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)16671.5%
Cap/Depr(5y)13050.2%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.12%
OCF growth 3YN/A
OCF growth 5YN/A

CANADIAN NORTH RESOURCES INC / CNRI.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CANADIAN NORTH RESOURCES INC?

ChartMill assigns a fundamental rating of 2 / 10 to CNRI.CA.


What is the valuation status of CANADIAN NORTH RESOURCES INC (CNRI.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CANADIAN NORTH RESOURCES INC (CNRI.CA). This can be considered as Overvalued.


How profitable is CANADIAN NORTH RESOURCES INC (CNRI.CA) stock?

CANADIAN NORTH RESOURCES INC (CNRI.CA) has a profitability rating of 2 / 10.


Can you provide the financial health for CNRI stock?

The financial health rating of CANADIAN NORTH RESOURCES INC (CNRI.CA) is 5 / 10.